Close Menu

Nuance

Nuance's CLU solution, which includes natural language processing capabilities that are tailored to the healthcare space, will "supplement" Watson's more general NLP abilities.

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

The firms will combine technology that IBM developed for Watson, including deep question answering, natural language processing, and machine learning capabilities, with Nuance's speech recognition and Clinical Language Understanding solutions to help physicians diagnose and treat patients.

The partners will combine their respective technologies in an effort to provide hospitals, physicians, and payers access to critical and timely information with a potential role in personalized medicine.

The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.

US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.

Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.

In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.